Physician profile
Victor Kwok
NPI 1497856827
$805.59
in general payments reported to CMS, 2019-2025
14 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $55.75 · 2021: $81.60 · 2022: $154 · 2023: $44.05 · 2024: $79.93 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $297 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.04 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $167.02 | 2019-2022 | |
| Novo Nordisk INC | $147.75 | 2023-2025 | Rybelsus, Ozempic |
| Amgen INC. | $97.46 | 2021-2025 | Evenity, Prolia |
| Lilly USA, LLC | $73.21 | 2022-2025 | Kisunla, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.14 | 2019-2023 | Jardiance |
| Gilead Sciences, INC. | $47.52 | 2019-2022 | |
| Glaxosmithkline, LLC. | $42.31 | 2020-2025 | Shingrix, Arexvy |
| Pfizer INC. | $40.91 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $31.95 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $23.97 | 2019 | |
| Sanofi Pasteur INC. | $20.01 | 2020 | |
| Abbvie INC. | $18.07 | 2022 | |
| Ironwood Pharmaceuticals, INC | $17.81 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Kwok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.